First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study

2016 ◽  
Vol 98 (1) ◽  
pp. 38-43 ◽  
Author(s):  
Nicolás Martínez-Calle ◽  
Ana Alfonso ◽  
José Rifón ◽  
Ignacio Herrero ◽  
Pedro Errasti ◽  
...  
Keyword(s):  
Overall Survival ◽  
Lymphoproliferative Disorders ◽  
First Line ◽  
Single Centre ◽  
Centre Study ◽  
Post Transplant ◽  
Single Centre Study

Post-Transplant CMV Screening and Prophylaxis - a Single Centre Study

2012 ◽  
Vol 94 (10S) ◽  
pp. 545
Author(s):  
S. Trivedi ◽  
G. Matthews ◽  
B. Featherstone ◽  
P. Jones ◽  
C. Watson ◽  
...  
Keyword(s):  
Single Centre ◽  
Centre Study ◽  
Post Transplant ◽  
Single Centre Study

Single-centre study reports a 84% five-year overall survival rate for paediatric solid tumours

2016 ◽  
Vol 105 (8) ◽  
pp. 952-958 ◽  
Author(s):  
Eero Teppo ◽  
Jarkko Penttinen ◽  
Outi Myöhänen ◽  
Kim Vettenranta ◽  
Olli Lohi
Keyword(s):  
Overall Survival ◽  
Survival Rate ◽  
Solid Tumours ◽  
Overall Survival Rate ◽  
Single Centre ◽  
Centre Study ◽  
Single Centre Study
Sign in / Sign up

Export Citation Format

Share Document